Medicine
Carbidopa and Levodopa 10 mg/100 mg tablet
Carbidopa and Levodopa 10 mg/100 mg tablet is a generic prescription medicine for oral use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°-30°C (59°-86°F). Protect…
Key facts
- Active ingredient (INN)
- Carbidopa and Levodopa
- Brand
- Sold under the generic name
- Strength
- 10 mg/100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 39 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaProficient RxAdvagen PharmaScieGen PharmaceuticalsA-S Medication SolutionsAvKARETeva Pharmaceuticals16 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°-30°C (59°-86°F). Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N04BA02 Carbidopa and Levodopa
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 October 2008
- Identifiers
- RxCUI 197443, 197444, 197445DailyMed set ID 87ab55c9-203d-d595-3e3e-0e38f2f6d9c4, 45909de3-0852-4e61-8a9e-23f8fcc2463a, 4ace5274-b6cf-414c-b9c0-f60e28a9cea5 +13NDC 75907-022, 0615-8555, 0093-9701 +13Application ANDA073618, ANDA074260, ANDA216505 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 16 labelers. The register lists 42 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 59651-456-01 | Aurobindo PharmaIndia | 28 November 2022 |
| 500 tablet in 1 bottle | 59651-456-05 | Aurobindo PharmaIndia | 28 November 2022 |
| 100 tablet in 1 bottle | 31722-381-01 | Camber PharmaceuticalsIndia | 27 May 2025 |
| 500 tablet in 1 bottle | 31722-381-05 | Camber PharmaceuticalsIndia | 27 May 2025 |
| 100 tablet in 1 bottle | 75907-022-01 | Dr. Reddy's LaboratoriesIndia | 1 May 2024 |
| 100 tablet in 1 bottle | 62756-517-08 | Sun Pharmaceutical IndustriesIndia | 28 October 2008 |
| 500 tablet in 1 bottle | 62756-517-13 | Sun Pharmaceutical IndustriesIndia | 28 October 2008 |
| 1000 tablet in 1 bottle | 62756-517-18 | Sun Pharmaceutical IndustriesIndia | 28 October 2008 |
| 30 tablet in 1 bottle | 62756-517-83 | Sun Pharmaceutical IndustriesIndia | 28 October 2008 |
| 100 tablet in 1 bottle | 62756-517-88 | Sun Pharmaceutical IndustriesIndia | 28 October 2008 |
| 1000 tablet in 1 bottle | 72888-106-00 | Advagen Pharma | 1 February 2023 |
| 100 tablet in 1 bottle | 72888-106-01 | Advagen Pharma | 1 February 2023 |
| 500 tablet in 1 bottle | 72888-106-05 | Advagen Pharma | 1 February 2023 |
| 30 tablet in 1 bottle | 72888-106-30 | Advagen Pharma | 1 February 2023 |
| 100 tablet in 1 bottle | 50228-457-01 | ScieGen Pharmaceuticals | 7 May 2021 |
| 500 tablet in 1 bottle | 50228-457-05 | ScieGen Pharmaceuticals | 7 May 2021 |
| 1000 tablet in 1 bottle | 50228-457-10 | ScieGen Pharmaceuticals | 7 May 2021 |
| 30 tablet in 1 bottle | 50228-457-30 | ScieGen Pharmaceuticals | 7 May 2021 |
| 100 tablet in 1 bottle | 0093-9701-01 | Teva Pharmaceuticals | 18 January 2022 |
| 500 tablet in 1 bottle | 0093-9701-05 | Teva Pharmaceuticals | 14 June 2022 |
| 100 tablet in 1 bottle | 52817-390-10 | TruPharma | 4 April 2023 |
| 500 tablet in 1 bottle | 52817-390-50 | TruPharma | 4 April 2023 |
| 100 tablet in 1 bottle | 72865-361-01 | XLCare Pharmaceuticals | 19 January 2026 |
| 1000 tablet in 1 bottle | 72865-361-10 | XLCare Pharmaceuticals | 19 January 2026 |
| 30 tablet in 1 bottle | 50090-7186-0 | A-S Medication Solutions | 26 June 2024 |
| 90 tablet in 1 bottle | 50090-7186-1 | A-S Medication Solutions | 26 June 2024 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 68002-100-04 | American Health Packaging | 28 July 2025 |
| 100 tablet in 1 bottle | 42291-471-01 | AvKARE | 24 June 2022 |
| 500 tablet in 1 bottle | 42291-471-50 | AvKARE | 24 June 2022 |
| 30 tablet in 1 blister pack | 67046-1614-3 | Coupler | 17 November 2025 |
| 100 tablet in 1 bottle, plastic | 71205-877-00 | Proficient Rx | 5 November 2021 |
| 1000 tablet in 1 bottle, plastic | 71205-877-11 | Proficient Rx | 5 November 2021 |
| 30 tablet in 1 bottle, plastic | 71205-877-30 | Proficient Rx | 5 November 2021 |
| 500 tablet in 1 bottle, plastic | 71205-877-55 | Proficient Rx | 5 November 2021 |
| 60 tablet in 1 bottle, plastic | 71205-877-60 | Proficient Rx | 5 November 2021 |
| 240 tablet in 1 bottle, plastic | 71205-877-64 | Proficient Rx | 5 November 2021 |
| 120 tablet in 1 bottle, plastic | 71205-877-72 | Proficient Rx | 5 November 2021 |
| 180 tablet in 1 bottle, plastic | 71205-877-78 | Proficient Rx | 5 November 2021 |
| 90 tablet in 1 bottle, plastic | 71205-877-90 | Proficient Rx | 5 November 2021 |
| 30 tablet in 1 blister pack | 0615-8555-39 | Vangard Labs | 24 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Carbidopa and Levodopa 10 mg/100 mg tablet.
Other strengths and forms of Carbidopa and Levodopa
Clinical summary
Carbidopa and Levodopa is a fixed-dose combination medicine indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. MedsAcross supplies Carbidopa and Levodopa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Carbidopa and LevodopaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SINEMET prescribing information (Organon) · U.S. National Library of Medicine, DailyMed
- Hopledo: European public assessment report (EPAR) · European Medicines Agency
- Onerji: European public assessment report (EPAR) · European Medicines Agency
Need Carbidopa and Levodopa 10 mg/100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.